Vitality Watch

Dossier clinicaltrials trial early 09-sep-2026
Small or early-phase human trial or pilot study

Targeting Aging With a Ketone Ester for Function in Frailty

Key claim: A multi-site randomized trial is testing whether daily ketone ester supplementation for 20 weeks improves strength, physical performance, inflammation markers, and general wellness in adults aged 65+ with mild functional decline.

Abstract

This study aims to find out if a food supplement that contains a naturally occurring substance, ketones, can help to improve strength and general wellness in adults at, or over the age of 65 years who are experiencing a slight decline in their physical function.

Participation will involve a screening visit and 4 additional study visits over the course of 20 weeks. After being assessed for eligibility, study participants will be sorted into two groups at random and consume either a ketone or placebo supplement at home every day for 20 weeks. Both study products can cause gastro-intestinal side effects in some individuals. At all study visits, subjects will provide blood samples. At three study visits, subjects will be asked to complete physical performance tests, provide blood, stool and urine samples. They will also complete questionnaires during three study visits to assess physical function, markers of inflammation, and other aspects of general well-being.

The study enrolls at three sites across the United States, in California (Buck Institute), Ohio (Ohio State University), and Connecticut (University of Connecticut). The study is coordinated by the San Francisco Coordinating Center (California Pacific Medical Center).

Why this matters

Ketone esters have circulated for years as a metabolic-biohack and endurance aid on anecdotal and mechanistic grounds; a 20-week multi-site RCT in older adults with mild functional decline is the first serious test of whether daily dosing moves hard functional endpoints rather than lab markers. The trial’s existence is a trend signal that exogenous ketones are being pulled from the biohacker fringe into geroscience-style frailty research, but no outcome data yet exists — the evidence gap between popular claims and tested effects remains wide until readout.

Source

Link

Briefing card

Targeting Aging With a Ketone Ester for Function in Frailty
Stage: trial early · clinicaltrials · 09-sep-2026

If you are an adult 65+ considering ketone esters for strength or frailty, results from this trial — not existing marketing — will be the first direct human functional evidence to weigh.

A multi-site randomized trial is testing whether daily ketone ester supplementation for 20 weeks improves strength, physical performance, inflammation markers, and general wellness in adults aged 65+ with mild functional decline.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06645847

build build 880 · 2bcef25 · 2026-11-18